Dramatic clinical response to ultra-high dose IVIg in otherwise treatment resistant inflammatory neuropathies

Abstract

These six cases demonstrate the safety and effectiveness of a treatment approach that includes individualised but evidence-based clinical assessment and, when necessary, high-doses of IVIg to restore patients' strength and ability to participate in activities of daily activities. Careful patient selection is important.